Download the ICS Branding Pack
Open Discussion Session 7 E-Poster 1 68 Efficacy and safety of mirabegron for the treatment of low compliant acontractile/underactive detrusor due to conus/cauda lesion: A prospective study
ICS Committee Member
Dr Pawan Vasudeva declared on the Tuesday 11th January 2022 that they did not have any existing or known future financial relationships or affiliations to disclose (NONE).
Developing World & IC Working Group